Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Tetracycline anion
Drug ID BADD_D02180
Description Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells.
Indications and Usage Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.
Marketing Status Discontinued; Prescription
ATC Code A01AB13; D06AA04; J01AA07; S01AA09; S02AA08; S03AA02
DrugBank ID DB00759
KEGG ID D00201
MeSH ID D013752
PubChem ID 27885548
TTD Drug ID D08NQZ
NDC Product Code Not Available
Synonyms Tetracycline | Tetrabid | 4-Epitetracycline | 4 Epitetracycline | Topicycline | Achromycin V | Hostacyclin | Tetracycline Hydrochloride | Tetracycline Monohydrochloride | Sustamycin | Achromycin
Chemical Information
Molecular Formula C22H23N2O8-
CAS Registry Number 60-54-8
SMILES CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)[O-])O)[O-])C(=O)N)[NH+](C)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Arthralgia15.01.02.001--
Body temperature increased13.15.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Enterocolitis07.08.03.003--
Eosinophilia01.02.04.001--
Fontanelle bulging17.02.05.006; 18.04.04.001--Not Available
Glossitis07.14.01.001--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Henoch-Schonlein purpura24.07.06.003; 23.06.01.002; 10.02.02.004; 01.01.04.001--Not Available
Hepatic failure09.01.03.002--
Hepatotoxicity12.03.01.008; 09.01.07.009--Not Available
Hypersensitivity10.01.03.003--
Menorrhagia21.01.03.002--
Nail discolouration23.02.05.001--
Nausea07.01.07.001--
Nephropathy toxic12.03.01.010; 20.05.03.002--Not Available
Neutropenia01.02.03.004--Not Available
Oesophageal ulcer07.04.05.002--
Oesophagitis07.08.05.001--
Onycholysis23.02.05.004--Not Available
Pericarditis02.06.02.001--
Photosensitivity reaction23.03.09.003--
Rash23.03.13.001--Not Available
Serum sickness12.02.08.004; 10.01.03.004--
The 1th Page    1 2    Next   Last    Total 2 Pages